ConcertAI is a data company that accelerates insights and improves outcomes for patients in healthcare. Its product portfolio includes a clinical trial optimization tool, data products, Predictive Patient, commercial solutions, its STAR AI and services. The company offers advanced data and AI for faster research and improved patient outcomes for cancers including AML, breast, gastric-esophageal, liver, lungs, melanoma, pancreatic, prostate and renal cancers. ConcertAI also offers data management, channel insights, gene therapy, specialty pharmacy contracting and patient journey management solutions, and therapeutic solutions for oncology, immunology, hematology, infectious diseases and psychiatry. It is privately held with an office in India.
No investor data is available
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.